Optos’ next-generation UWF device expands imaging modality

Optos’ next-generation, ultra-widefield (UWF) imaging platform (California) provides greater imaging functionality and introduces the company’s newest imaging modality-indocyanine green angiography (ICG) while maintaining all current color imaging modalities, autofluorescence (AF) and fluorescein angiography (FA).

In addition to ICG retinal imaging, the platform has several software and hardware enhancements, including the OptosAdvance software platform with advanced tools and an easier procedure workflow. New proprietary optical hardware allows resolution to be optimized and maintained throughout the scan of the retina resulting in more clarity in the far periphery.

ProView enhances image registration for tracking retinal disease development over time and comparing images across all retinal image modalities. This functionality removes systematic image variations providing an accurate representation of anatomical features in the retina.

“The addition of ICG in our newest UWF device provides retinal specialists and ophthalmologists with more imaging tools allowing them to see and treat retinal pathology more effectively,” said Roy Davis, chief executive officer of Optos.

First shipments of the  compact, table-top, UWF retinal imaging device have commenced, the company announced.

The introduction of the system means ophthalmologists “have all of the current image modalities with the added benefit of ICG angiography imaging,” said SriniVas R. Sadda, MD, Doheny Eye Institute, and an early user of the platform. “ICG is going to be huge because it is an important component in treating difficult disease, such as uveitis.”